Q4 2025 earnings call highlights: beat on revenue/EPS, Diagnostics strength, AI software catalyst, and 2026 guidance.

Revvity, Inc. is rated a Hold due to stretched valuation, ongoing weakness in China diagnostics and NIH funding. Read more on ...

Revvity Balances Earnings Strength With Cautious 2026 Outlook Revvity’s latest earnings call painted a picture of a company executing well financially while bracing for a tough macro and sector ...

Acquisition and investment launch a national, vertically integrated infrastructure for personalized, value-based, ...

KEV Group, the makers of SchoolCash and the leading provider of K–12 school finance management solutions, today announced the ...

TikTok has finalized a deal to create a new American entity, avoiding the looming threat of a ban in the U.S. that has been ...

VetsinTech will unveil "Vets in Space," a flagship event hosted by The Walt Disney Company at the historic Grand Central Air Terminal Museum in Southern California. This groundbreaking initiative ...

A new humanoid robot named Sprout, developed by Fauna Robotics, is making its debut. Unlike sleek and powerful-looking machines from companies like Tesla, Sprout is designed to be approachable and ...

I am proud of what we were able to accomplish last year, as we were able to achieve both our organic growth and adjusted EPS expectations that were either in line to above our guidance coming into the ...

Wall Street is drifting through mixed trading, as technology stocks sink again. The S&P 500 slipped 0.2% Wednesday, coming ...